Back
Entrada Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37
TRDA
Entrada Therapeutics
Last Price:
$17.60
Seasonality Move:
-24.47%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's Legacy-Defining Momentor Strike
But the Surprising Way Trump Solves it Could Cement His Legacy.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TRDA is experiencing slight buying pressure.
Entrada Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.02 | Sell |
| 20-day SMA: | 19.27 | Sell |
| 50-day SMA: | 18.48 | Sell |
| 200-day SMA: | 15.77 | Buy |
| 8-day EMA: | 18.11 | Sell |
| 20-day EMA: | 18.7 | Sell |
| 50-day EMA: | 18.33 | Sell |
| 200-day EMA: | 16.47 | Buy |
Entrada Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.27 | Sell |
| Relative Strength Index (14 RSI): | 41.98 | Sell |
| Chaikin Money Flow: | 106552 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.67 - 20.29) | Sell |
| Bollinger Bands (100): | (15.2 - 18.88) | Buy |
Entrada Therapeutics Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Entrada Therapeutics Stock
Is Entrada Therapeutics Stock a Buy?
-
Entrada Therapeutics share price is 17.60 while TRDA 8-day simple moving average is 18.02, which is a Sell signal.
-
The stock price of TRDA is 17.60 while Entrada Therapeutics 20-day SMA is 19.27, which makes it a Sell.
-
Entrada Therapeutics 50-day simple moving average is 18.48 while TRDA share price is 17.60, making it a Sell technically.
-
TRDA stock price is 17.60 and Entrada Therapeutics 200-day simple moving average is 15.77, creating a Buy signal.
TRDA Technical Analysis vs Fundamental Analysis
Sell
37
Entrada Therapeutics (TRDA)
is a Sell
Is Entrada Therapeutics a Buy or a Sell?
-
Entrada Therapeutics stock is rated a SellThe current Entrada Therapeutics [TRDA] share price is $17.60. The Score for TRDA is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Entrada Therapeutics Stock Info
Market Cap:
658.6M
Price in USD:
17.60
Share Volume:
357.3K
Entrada Therapeutics 52-Week Range
52-Week High:
21.79
52-Week Low:
11.35
Sell
37
Entrada Therapeutics (TRDA)
is a Sell
Entrada Therapeutics Share Price Forecast
-
What is the Entrada Therapeutics stock price today?The Entrada Therapeutics stock price is 17.60 USD today.
-
Will TRDA stock go up or go down?Entrada Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Entrada Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Entrada Therapeutics is overvalued.
Is Entrada Therapeutics Stock a Buy?
-
Entrada Therapeutics share price is 17.60 while TRDA 8-day exponential moving average is 18.11, which is a Sell signal.
-
The stock price of TRDA is 17.60 while Entrada Therapeutics 20-day EMA is 18.70, which makes it a Sell.
-
Entrada Therapeutics 50-day exponential moving average is 18.33 while TRDA share price is 17.60, making it a Sell technically.
-
TRDA stock price is 17.60 and Entrada Therapeutics 200-day simple moving average is 16.47, creating a Buy signal.
Fundamental Analysis of Entrada Therapeutics
Is Entrada Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.13 per share, and a decrease next year of $4.09 per share.
Technical Analysis of Entrada Therapeutics
Should I short Entrada Therapeutics stock?
-
TRDA Moving Average Covergence Divergence (MACD) indicator is -0.27, suggesting Entrada Therapeutics is a Sell
-
Entrada Therapeutics Relative Strength Index (RSI) is 41.98, which suggest Entrada Therapeutics is oversold
-
The Bollinger Bands (25) for Entrada Therapeutics is (17.67 - 20.29), which suggest Entrada Therapeutics is a Buy
-
The Bollinger Bands (100) for Entrada Therapeutics is (15.2 - 18.88), which suggest Entrada Therapeutics is a Buy
* Entrada Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.